Package 0409-0125-25

Brand: labetalol hydrochloride

Generic: labetalol hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0409-0125-25
Digits Only 0409012525
Product NDC 0409-0125
Product ID 0409-0125_c1772ea4-65eb-4f27-8e33-3de06278acfe
Description

25 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25) / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01)

Marketing

Marketing Status
Marketed Since 2023-08-07
Brand labetalol hydrochloride
Generic labetalol hydrochloride
Sample Package No

Linked Drug Pages (1)

Labetalol Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "c1772ea4-65eb-4f27-8e33-3de06278acfe", "openfda": {"unii": ["1GEV3BAW9J"], "rxcui": ["896771"], "spl_set_id": ["abfc6b75-1ed5-41f1-0484-4597488237bc"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25)  / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01)", "package_ndc": "0409-0125-25", "marketing_start_date": "20230807"}], "brand_name": "Labetalol Hydrochloride", "product_id": "0409-0125_c1772ea4-65eb-4f27-8e33-3de06278acfe", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "0409-0125", "generic_name": "Labetalol Hydrochloride", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Labetalol Hydrochloride", "active_ingredients": [{"name": "LABETALOL HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "ANDA075240", "marketing_category": "ANDA", "marketing_start_date": "20230807", "listing_expiration_date": "20261231"}